Single-shot inversion recovery TrueFISP for assessment of myocardial infarction

American Journal of Roentgenology

Volumn 186, Issue 3, 2006, Pages 627-633

  Huber, Armin ^a   Schoenberg, Stefan O ^a   Spannagl, Benedikt ^a   Rieber, Johannes ^a   Erhard, Isabelle ^a   Klauss, Volker ^a   Reiser, Maximilian F ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Heart; Ischemia; MR contrast agents; MRI; Myocardial infarction

Indexed keywords

GADODIAMIDE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGED; APPARATUS; ARTICLE; BREATH HOLDING; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; IMAGE RECONSTRUCTION; IMAGING SYSTEM; MALE; PRIORITY JOURNAL; SIGNAL DETECTION; SINGLE SHOT TRUE FAST IMAGING WITH STEADY STATE PRECESSION SEQUENCE; TURBO FAST LOW ANGLE SHOT SEQUENCE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; AGED; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 33645799690     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.04.0746     Document Type: Article

References (21)

1. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 9:1992-2002
2. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445-1453
3. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003; 108:1945-1953
4. Jimenez Borreguero LJ, Ruiz-Salmeron R. Assessment of myocardial viability in patients before revascularization. Rev Esp Cardiol 2003; 56:721-733
5. Nguyen TD, Nuval A, Mulukutla S, Wang Y. Direct monitoring of coronary artery motion with cardiac fat navigator echoes. Magn Reson Med 2003; 50:235-241
6. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218:215-223
7. Huber A, Schonberg SO, Spannagl B, Rieber J, Klauss V, Reiser MF. Determining myocardial vitality in myocardial infarction: comparison of single and multislice MRI techniques with TurboFLASH and TrueFISP sequences [in German]. Radiologe 2004; 44:146-151
8. Scheffler K, Henning JT. Quantification with inversion recovery TrueFISP. Magn Reson Med 2001; 45:720-723
9. Chung YC, Lee VS, Laub G, Simonetti OP. Inversion recovery cine TrueFISP. ISMRM Tenth Annual Meeting 18-24 May, 2002, Honolulu, HI. Berkeley, CA: International Society for Magnetic Resonance in Imaging, 2002:219
10. Spuentrup E, Buecker A, Karassimos E, Gunther RW, Stuber M. Navigator-gated and real-time motion corrected free-breathing MR imaging of myocardial late enhancement. Rofo 2002; 174:562-567
11. Nilsson JC, Nielsn G, Groenning BA, et al. Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Heart 2001; 85:639-642
12. Schulz-Menger J, Gross M, Messroghli D, Uhlich F, Dietz R, Friedrich M. Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol 2001; 42:513-518
13. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001; 104:2838-2842
14. Chiu CW, So NM, Lam WW, Chan KY, Sanderson JE. Combined first-pass perfusion and viability study at MR imaging in patients with non-ST segment-elevation acute coronary syndromes: feasibility study. Radiology 2003; 226:717-722
15. 18F-labeled fluorodeoxyglucose and N-12 ammonia. Circulation 1983; 67:766-778
16. Klein C, Nekolla SG, Bengel F, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2001; 105:162-167
17. Kloner RA, Przyklenk K. Hibernation and stunning of the myocardium. N Engl J Med 1991; 325:1877-1879
18. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117:211-221
19. Vanoverschelde JL, Wijns W, Borgers M, et al. Chronic myocardial hibernation in humans: from bedside to bench. Circulation 1997; 95:1961-1971
20. Zamorano J, Delgado J, Almeria C, et al. Reasons for discrepancies in identifying myocardial viability by thallium-201 redistribution, magnetic resonance imaging, and dobutamine echocardiography. Am J Cardiol 2002; 90:455-459
21. Kuhl HP, Beek AM, van der Weerdt AP, et al. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2003; 41:1341-1348